產品屬性：
產品名稱 | ZT-12-037-01 |
規格 | 1mg、5mg |
貨號 | EY-01Y17359 |
Cas No.: 2328073-61-4
別名: N/A
化學名: N/A
分子式: C21H31N5O2
分子量: 385.5
溶解度: DMSO: 8.33 mg/mL (21.61 mM)
儲存條件: Store at -20°C
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
產品描述：
ZT-12-037-01 is a STK19-targeted inhibitor, has a high-affinity interaction with STK19 protein and inhibits oncogenic NRAS-driven melanocyte malignant transformation. ZT-12-037-01 is an ATP-competitive inhibitor, inhibiting phosphorylation of NRAS (major isoform of Ras family) with an IC50 of 24 nM[1].ZT-12-037-01 (3 μM; 14 days) significantly inhibits mutant NRAS-STK19-driven melanocyte colony formation and proliferation[1].ZT-12-037-01 (0-3 μM) has an inhibitory effects of ZT-12-037-01 on STK19WT and STK19D89N-activated NRAS phosphorylation in HPMs[1].Cell Proliferation Assay[1] Cell Line:CDK4 (R24C) melanocyte cells; hTERT melanocyte cells; p53DD melanocyte cellsZT-12-037-01 (injection subcutaneously; 25-50 mg/kg; once daily; 21 days) inhibits growth of SK-MEL-2 xenograft melanoma and the sections of tumors indicates induction of apoptosis by increasing cleaved caspase-3[1].
特別提醒公司產品僅供科研使用
